9 Comments
Mar 17Liked by Siguna Mueller, Ph.D., Ph.D.

It's also mentioned in this book chapter https://pubmed.ncbi.nlm.nih.gov/33539013/

Expand full comment
author

Thank you for the link. Looks like a very interesting chapter/book. Do they also discuss the EVs as an alternative carrier, i.e. something in the context of the mRNA vaccines? Or is it more generally about characteristics of EVs for communication? Thank you.

Expand full comment
Mar 18Liked by Siguna Mueller, Ph.D., Ph.D.

Try this one https://pubmed.ncbi.nlm.nih.gov/36232549/

Expand full comment
author

Thank you. Very interesting that EV-based vaccines are developed to combat the many downsides and dangers of the LNP carriers. I just wonder why there is not an even greater outcry amongst scientists against the LNP components in the mRNA COVID-19 vaccines alone. I mean, the LNP aspect by itself demonstrates the mass experiments that have been and are conducted and that so many of the most basic questions are unresolved. To me, it's also terrifying that the new platforms based on the EVs are even more stable.... and, if they can be inhaled as a vaccine, then they can also be exhaled into the environment carrying all sorts of biologically active material. I do not agree EVs are harmless just because they are known to exist naturally as well. Are we just in for another mass-experimentation?!

Expand full comment
Mar 18Liked by Siguna Mueller, Ph.D., Ph.D.

Do you know this review form Jan 2020 https://www.mdpi.com/2079-4991/10/2/190? Fig 1 sums it up very nicely. I don't think the problems were solved within 2 months.

Expand full comment
author

Really troubling. I had already summarized a number of their toxic effects in my book. This article confirms many of them and takes them further yet. Indeed, it's really an interesting timing when the article was published! It would have been brand-new when BigPharma began (?) to work on their vaccines.

Expand full comment
Mar 18Liked by Siguna Mueller, Ph.D., Ph.D.

They could have read it. It is just a review. Easy to understand. So they had to know.

Expand full comment
Mar 16Liked by Siguna Mueller, Ph.D., Ph.D.

Thanks Siguna! Nicely laid out. Thank you for the Maugeri article. I remember reading it a while ago. The implications are huge of course. Does it explain the ongoing spike protein production? "Shedding" is bad enough, but being re-transfected with EVs? Truly disturbing.

Expand full comment
author

Thank you. I think they give some strong evidence for this. They are injecting intravenously. But their main points really apply to what happens after the RNA-LNP gets taken up by some cells. They describe the fate thereafter. IMHO opinion, it should not matter then how it got there in the first place, e.g., if it alternatively had been via an intramuscular injection -- the LNPs will still disseminate it to some extent. Also, they did not analyze the spike per se. But I would not see why a different cargo would be that much different. Yes, it is disturbing. There was NO INDICATOR of "it all/mostly staying in the arm." Much the opposite.

Expand full comment